Cellebrite DI announced that Haim Shani has retired as a director of the Company, effective immediately. Mr. Shani had been a distinguished member of the Board since 2019, including two years as Chairman from August 2021 until August 2023. Following Mr. Shani’s departure, Cellebrite’s Board of Directors shall consist of nine directors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLBT:
- Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase
- Cellebrite upgraded to Buy at BofA on improved business momentum
- Cellebrite upgraded to Buy from Neutral at BofA
- Cellebrite price target raised to $15 from $10 at TD Cowen
- Cellebrite sees FY24 revenue $370M-$380M, consensus $370.76M